This is a preview of subscription content, log in via an institution to check access.
Notes
The study results are published in the May edition of Transfusion (Journal of the American Association of Blood Banks).
References
Food and Drug Administration. FDA approves first DNA-based test to detect cystic fibrosis. Media release: 9 May 2005
Tm Bioscience. Tm Bioscience receives FDA clearance for cystic fibrosis DNA test. Media release: 9 May 2005
FDA clears Tm Bioscience cystic fibrosis gene test via de novo. Gray Sheet 2005; 31 (20): 30
BioArray Solutions. New bead array technology able to provide rapid comprehensive DNA typing of blood donors. Media release 10 May 2005
The Children’s Hospital of Philadelphia. Chromosome Deletion Predicts Aggressive Neuroblastoma. Media release: 18 May 2005
Nymox Pharmaceutical. Nymox PMA slated for FDS advisory panel meeting. Media release: 25 Apr 2005
Nymox says AlzheimAlert diagnostic will be considered by FDA panel. Gray Sheet 2005; 31 (20): 16
University of Oxford. European consortium to tackle diabetes at the molecular level. Media release: 15 Apr 2005
Development of Disease Biomarkers [online]. Available at: http://grants2.nih.gov/grants/guide/pa-files/PA-05-098.html [Accessed 2005 May 4]
Rights and permissions
About this article
Cite this article
Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 3, 16–17 (2005). https://doi.org/10.1007/BF03256965
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256965